Kinnate Biopharma Inc.
KNTE · NASDAQ
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $56,998 | $51,662 | $34,507 | $73,570 |
| Short-Term Investments | $97,036 | $115,914 | $150,196 | $127,411 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4,143 | $2,725 | $3,897 | $4,307 |
| Total Curr. Assets | $158,177 | $170,301 | $188,600 | $205,288 |
| Property Plant & Equip (Net) | $4,760 | $5,130 | $5,625 | $6,047 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $10,630 | $12,762 | $19,579 | $30,203 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $38 | $2,516 | $2,331 | $2,342 |
| Total NC Assets | $15,428 | $20,408 | $27,535 | $38,592 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $173,605 | $190,709 | $216,135 | $243,880 |
| Liabilities | – | – | – | – |
| Payables | $2,031 | $2,929 | $2,696 | $4,451 |
| Short-Term Debt | $892 | $869 | $959 | $983 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $9,072 | $11,976 | $12,118 | $12,721 |
| Total Curr. Liab. | $11,995 | $15,774 | $15,773 | $18,155 |
| LT Debt | $2,283 | $2,515 | $2,742 | $2,963 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $2,283 | $2,515 | $2,742 | $2,963 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2,283 | $3,384 | $3,701 | $3,946 |
| Total Liabilities | $14,278 | $18,289 | $18,515 | $21,118 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $5 | $5 | $5 | $5 |
| Retained Earnings | -$372,012 | -$354,954 | -$324,221 | -$292,303 |
| AOCI | -$12 | -$147 | -$342 | -$464 |
| Other Equity | $531,346 | $527,516 | $522,178 | $515,524 |
| Total Equity | $159,327 | $172,420 | $197,620 | $222,762 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $173,605 | $190,709 | $216,135 | $243,880 |
| Net Debt | -$53,823 | -$48,278 | -$30,806 | -$69,624 |